APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
about
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodiesHIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodiesRestriction of foamy viruses by APOBEC cytidine deaminasesAdaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificitiesDifferential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cellsRole and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsDifferential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activityThe localization of APOBEC3H variants in HIV-1 virions determines their antiviral activityDifferential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesHuman LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activityHIV-1 Vif, APOBEC, and intrinsic immunityAlternative induction of meiotic recombination from single-base lesions of DNA deaminasesA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyAll APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3GIntracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and humanNatural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversificationDual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retrovirusesThe APOBEC3 family of retroelement restriction factorsHIV-1 reverse transcriptionComparison of antiviral activity of lambda-interferons against HIV replication in macrophagesStructural Insights into HIV-1 Vif-APOBEC3F InteractionCross-Species Virus Transmission and the Emergence of New Epidemic DiseasesEvasion of host immune defenses by human papillomavirusReversed functional organization of mouse and human APOBEC3 cytidine deaminase domainsTarget cell APOBEC3C can induce limited G-to-A mutation in HIV-1Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2nPopulation genomic analysis reveals a rich speciation and demographic history of orang-utans (Pongo pygmaeus and Pongo abelii)APOBEC3G: an intracellular centurionSIV replication in human cellsCellular inhibitors of long interspersed element 1 and Alu retrotransposition.Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.
P2860
Q21090536-F76E013A-0486-434B-857D-0355E4F3CD73Q24297395-D78B3FC6-67CD-4DD7-B1A4-E085D46CF2A7Q24299944-00495440-3516-498B-AA22-1ABD95A06716Q24311896-51398DE7-6958-48EB-A517-AE54A5524B8BQ24317568-F2B42F75-8501-45EE-B0EC-C422782A2179Q24321636-02463BE8-8816-4A89-9DC3-03C6EE004166Q24521469-0BADDA9C-32B8-421B-87F7-FB9A0039720BQ24529150-0D7C5945-AB59-480E-B505-EB6218D369E0Q24536003-E62B4CC7-0675-47DD-94A5-79E918DE3733Q24537623-32425400-483E-4ECE-B115-FD4137DF46C8Q24544264-7DFD6D6B-5556-472E-BB85-7F038B18E006Q24565021-67F250A5-3BC4-473A-AA86-B76CCACE3A81Q24596322-79EB8184-64F9-4F85-8D3E-4364B9C55021Q24612992-15A663FE-9396-4C91-8499-BA6130D264E1Q24625056-20889B66-5437-422E-9358-B1AC24727CB9Q24647833-F3AD5650-5519-412F-B64F-CA9BE8257F49Q24652699-2C5BD1D6-EE7A-4D6B-A0EB-A9CD09701CC2Q24656551-6B4CDC50-146E-4E3D-BFAA-AD199E94DB73Q24670173-6B0CB0B1-8AD2-4FFE-BCE1-E58135271404Q24675735-D18D456F-39CB-4C84-B4EC-7E96F465E55DQ24681427-4F099E2B-A9B5-4459-B2B7-68D8655DEE76Q24805644-14B95CF5-5641-46C2-B96B-197006F6BB7DQ24812692-06C38A59-EC28-4413-B082-DF6571543561Q24817186-D1E8957B-B384-4C60-B257-C8FEFC9FBB55Q25257798-A0B99273-A151-4850-A637-BC053B3F35E8Q26862780-2AC6E26C-570A-41B8-B79C-D9538985D770Q27023387-EC90119F-C7C6-4091-9FBA-3DF7569EF332Q27307732-FC302BEA-3E05-441F-AFCD-E348E845B912Q27321018-30E13949-1D5C-4F40-A018-B9D644622D7FQ27486915-7B55A963-F5DA-4F5D-A35F-2872EDC66569Q28076194-BFB0FA5E-23DA-4D48-A612-AEC6EFED932FQ28266980-838BCDF1-E0F4-4663-A7F1-DA62F1DDAE5BQ28469342-47A340BD-4F46-4394-A40B-0D1AE7292DAEQ28481286-6193E5B8-D140-4E7A-8B99-EE1CBC4B084FQ28662181-0550EF91-CD7B-4ACA-802E-40816FE7A686Q28754989-DDA2B7F6-D816-471C-89F0-2F07009382E2Q30417737-2AD42F72-88E9-4B4D-8DF9-71F89D7D0DA8Q30445599-1466B1BA-48CE-430E-A52C-574E79BCA85DQ30483676-987D3F69-18A1-41CF-ACBA-CC14606F62E1Q33385376-1F5AEEA6-9814-460B-B0BF-768FE93D02A9
P2860
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@ast
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@en
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@nl
type
label
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@ast
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@en
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@nl
prefLabel
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@ast
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@en
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@nl
P2093
P3181
P356
P1476
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
@en
P2093
Darlene Chen
Derya Unutmaz
Nathaniel R Landau
Renate König
Roberto Mariani
P304
P3181
P356
10.1074/JBC.M408802200
P407
P577
2004-12-17T00:00:00Z